MaxCyte: A Pioneer in the Cell Therapy Market
MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT) is a leading, cell-engineering-focused company providing platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and to support innovative, cell-based research. MaxCyte, Inc. (NASDAQ: MXCT) Market Cap: $550.54M; Current Share Price: $5.35 Data by YCharts The Company and its...
